Pomeranian Medical University

The Pomeranian Medical University site in Szczecin conducts extensive research in neoplasms, with a strong focus on acute leukemias, lymphomas, myeloma, and solid tumors. These trials are designed to improve treatment effectiveness, reduce relapse risk, and support better outcomes for both adults and children with blood cancers and other malignancies.

• Studies in acute lymphoblastic leukemia, acute myeloid leukemia, and lymphoblastic lymphoma are testing more effective cancer treatment strategies.
• Research also includes classical Hodgkin lymphoma, multiple myeloma, and central nervous system lymphomas to evaluate new therapeutic options.
• Trials in ovarian cancer, hepatoblastoma, hepatocellular carcinoma, and colorectal cancer aim to improve disease control and survival.

Much of this work focuses on comparing new combinations, improving response rates, and tailoring care to disease subtype and patient risk.

This research portfolio includes a wide range of congenital, hereditary, and neonatal diseases, with particular attention to children and adolescents. The trials explore better ways to manage rare and complex conditions while preserving long-term health and quality of life.

• Phenylketonuria, Prader-Willi syndrome, and growth hormone deficiency are studied to support metabolic control and growth.
• Trials in congenital adrenal hyperplasia and presymptomatic type 1 diabetes aim to improve early disease management and prevention.
• Research in children with leukemia and malignant liver tumors focuses on safer, more effective treatment approaches.

These studies often combine treatment evaluation with efforts to better understand rare pediatric disorders and their long-term impact.

The site has a strong presence in immune system diseases, musculoskeletal diseases, and nervous system diseases. Clinical trials are exploring new therapies for chronic inflammatory and autoimmune disorders that can significantly affect daily functioning.

• Systemic lupus erythematosus, idiopathic inflammatory myopathy, and chronic graft versus host disease are being studied to improve immune control.
• Trials in myasthenia gravis, CIDP, and secondary progressive multiple sclerosis aim to slow progression and improve symptoms.
• Giant cell arteritis and SAPHO syndrome are included in research seeking better symptom relief and disease remission.

Overall, this area emphasizes testing targeted therapies that may reduce inflammation while improving function and quality of life.

Clinical research at the department also covers hormonal diseases, nutritional and metabolic diseases, and genetic phenomena. These trials are aimed at improving disease control, preserving organ function, and supporting healthier development over time.

• Type 1 diabetes and Graves’ disease are studied to improve endocrine control and immune-related outcomes.
• Phenylketonuria trials focus on lowering harmful metabolite levels and protecting neurocognitive development.
• Research in Prader-Willi syndrome and growth hormone deficiency evaluates treatments intended to support growth and daily functioning.

These studies reflect a broader effort to refine long-term care for inherited and metabolic conditions across childhood and adulthood.

Another major research stream involves cardiovascular diseases, respiratory tract diseases, and anesthesia and analgesia. The trials are focused on improving safety, preventing complications, and strengthening treatment outcomes in both surgical and medical settings.

• Heart failure and myocardial injury after noncardiac surgery are studied to improve cardiovascular protection.
• Chronic obstructive pulmonary disease, interstitial lung disease secondary to systemic sclerosis, and chronic rhinosinusitis with nasal polyps are included in respiratory research.
• Perioperative studies examine general anesthesia and reversal of anticoagulation to support safer procedures.

At Centrum Wsparcia Badań Klinicznych, these trials aim to reduce risk and improve care around surgery, breathing disorders, and heart disease.